The Middle East Retinoic Acid Market was valued at USD 29.8 million in 2025 and is projected to reach USD 41.1 million by 2032, growing at a Compound Annual Growth Rate (CAGR) of 5.4% during the forecast period (2024–2032). This growth is being driven by the rising prevalence of dermatological conditions, increasing consumer spending on advanced skincare, and the expanding therapeutic applications of retinoic acid in oncology and regenerative medicine across the region.

As the healthcare and personal care industries in the Middle East advance, the spotlight is on the key pharmaceutical and specialty chemical suppliers who are driving innovation, formulation stability, and access to critical therapies. In this blog, we profile the Top 10 Companies in the Middle East Retinoic Acid Industry—a mix of multinational giants, regional powerhouses, and specialized manufacturers shaping the future of dermatological and therapeutic care.

---

🔟 1. Teva Pharmaceutical Industries Ltd.

Headquarters: Tel Aviv, Israel
Key Offering: Pharmaceutical-grade Retinoic Acid, Topical Creams & Gels, Oral Formulations

Teva is a global pharmaceutical leader and a dominant force in the Middle Eastern active pharmaceutical ingredient (API) and generic drug market. The company supplies high-purity retinoic acid for compounding and manufactures a range of finished dosage forms for treating acne and other skin conditions, leveraging its extensive regional distribution network.

Innovation & Strategic Focus:

• Investment in advanced, low-irritation topical delivery systems

• Strong portfolio of generic dermatological products containing retinoids

• Strategic partnerships with regional distributors and healthcare providers

Download FREE Sample Report:
Middle East Retionic Acid Market – View in Detailed Research Report

---

9️⃣ 2. Hikma Pharmaceuticals PLC

Headquarters: Amman, Jordan
Key Offering: Retinoic Acid APIs, Branded & Generic Dermatology Products

Hikma is a major regional pharmaceutical manufacturer with a significant footprint across the GCC and MENA regions. Its injectables and generics divisions utilize retinoic acid in formulations, and the company is actively expanding its dermatology segment to capitalize on growing market demand for advanced skincare treatments.

Innovation & Strategic Focus:

• Expansion of local manufacturing capabilities for APIs and finished products

• Focus on developing combination therapies for enhanced efficacy

---

8️⃣ 3. Taro Pharmaceutical Industries Ltd.

Headquarters: Haifa, Israel
Key Offering: Topical Retinoic Acid Formulations (Creams, Gels)

A subsidiary of Sun Pharmaceutical Industries, Taro specializes in topical dermatological products. The company is a key supplier of prescription-strength retinoic acid creams and gels in the Middle East, known for its focus on quality control and manufacturing excellence.

Innovation & Strategic Focus:

• Development of patented vehicle technologies to improve skin tolerance

• Robust pipeline of dermatological products targeting specific regional needs

---

7️⃣ 4. Neopharma LLC

Headquarters: Abu Dhabi, United Arab Emirates
Key Offering: Pharmaceutical Formulations, Contract Manufacturing Services

Neopharma is one of the UAE’s leading pharmaceutical manufacturers, playing a crucial role in the region’s supply chain. The company engages in the formulation of drugs containing retinoic acid and offers contract manufacturing services, supporting both local brands and multinational companies seeking regional production.

Innovation & Strategic Focus:

• Strategic investments in state-of-the-art formulation and R&D facilities

• Partnerships with global firms for technology transfer and localization

Download FREE Sample Report:
Middle East Retionic Acid Market – View in Detailed Research Report

---

6️⃣ 5. Julphar Gulf Pharmaceutical Industries

Headquarters: Ras Al Khaimah, United Arab Emirates
Key Offering: A Broad Range of Generic Pharmaceuticals, including Dermatologicals

Julphar is a major pan-Arab pharmaceutical manufacturer with a wide distribution network. The company produces and markets a variety of generic drugs, including those in the dermatology space where retinoic acid is a key ingredient, ensuring affordable access to essential treatments across the Middle East and Africa.

Innovation & Strategic Focus:

• Focus on backward integration and API manufacturing

• Expansion of product portfolio in high-growth therapeutic areas like dermatology

---

5️⃣ 6. Tabuk Pharmaceutical Manufacturing Company

Headquarters: Tabuk, Saudi Arabia
Key Offering: Pharmaceuticals, Nutraceuticals, and Cosmetic Products

As a leading Saudi manufacturer, Tabuk plays a vital role in the kingdom’s Vision 2030 goal of strengthening local pharmaceutical production. The company is involved in formulating products that may utilize retinoic acid derivatives and is expanding its capabilities in sophisticated drug delivery systems.

Innovation & Strategic Focus:

• Aligning with national Saudization and drug security initiatives

• Investing in R&D for products suited to the regional population

---

4️⃣ 7. Jamjoom Pharma

Headquarters: Jeddah, Saudi Arabia
Key Offering: Prescription Pharmaceuticals, Over-the-Counter (OTC) Products

Jamjoom Pharma is a fast-growing Saudi pharmaceutical company with a significant market share in the kingdom and broader MENA region. The company markets a diverse portfolio and has the potential to be a key player in distributing and manufacturing retinoid-based treatments for the expanding local dermatology market.

Innovation & Strategic Focus:

• Strategic licensing agreements with international innovator companies

• Building a strong sales and marketing force focused on specialty care

---

3️⃣ 8. ACDIMA International

Headquarters: Amman, Jordan
Key Offering: Retinoic Acid as a Reference Standard, Fine Chemicals

ACDIMA specializes in the production of high-purity fine chemicals, pharmaceutical intermediates, and reference standards. The company is a critical supplier of certified retinoic acid standard materials to quality control laboratories, research institutions, and regulatory bodies across the Middle East, ensuring product quality and compliance.

Innovation & Strategic Focus:

• Maintaining cGMP and ISO standards for high-purity chemical manufacturing

• Serving the region’s growing life sciences research and development sector

---

2️⃣ 9. Rameda Pharmaceuticals

Headquarters: Giza, Egypt
Key Offering: Generic Pharmaceuticals across Multiple Therapeutic Areas

Rameda is a leading Egyptian pharmaceutical company with a strong export orientation across the Arab and African markets. Its extensive portfolio includes dermatological products, positioning it as a significant formulator and supplier of affordable retinoic acid-based generics to a large population base.

Innovation & Strategic Focus:

• Continuous expansion of manufacturing capacity and product lines

• Leveraging Egypt’s strategic location for export-led growth

---

1️⃣ 10. Specialty Chemical Importers & Distributors

Headquarters: Various across GCC (e.g., Dubai, UAE; Dammam, KSA)
Key Offering: Importation, Distribution, and Supply of Retinoic Acid Raw Material

A network of specialized chemical distributors, such as those operating in Jebel Ali (UAE) or through Saudi industrial cities, forms the backbone of the raw material supply chain. These companies import high-quality retinoic acid from global producers in Asia, Europe, and the Americas, ensuring a steady supply for regional pharmaceutical and cosmetic manufacturers.

Innovation & Strategic Focus:

• Maintaining complex cold-chain and stable logistics for sensitive APIs

• Providing technical support and regulatory documentation to end-users

Get Full Report Here:
Middle East Retionic Acid Market – View in Detailed Research Report

---

🌍 Outlook: The Future of Retinoic Acid in the Middle East is Precision and Personalization

The Middle East retinoic acid market is undergoing a significant evolution. While traditional acne treatments continue to drive volume, the industry is increasingly focused on advanced formulation technologies, expansion into novel therapeutic areas, and customization for regional demographics and climates.

📈 Key Trends Shaping the Market:

• Accelerated adoption of microencapsulation and sustained-release technologies to minimize irritation

• Growing research into retinoic acid’s application in oncology and regenerative medicine within regional academic centers

• Rise of medical aesthetics and dermatology clinics creating demand for professional-grade, high-strength formulations

• Government policies, like Saudi Vision 2030, incentivizing local pharmaceutical manufacturing and API production

Get Full Report Here:
Middle East Retionic Acid Market – View in Detailed Research Report

The companies listed above are not only supplying a critical therapeutic ingredient—they are enabling the region’s transition towards more sophisticated, accessible, and effective dermatological and medical care.